In many individuals infected with human immunodeficiency virus (HIV), the immunosuppressive effects of the virus will be accompanied by another serious complication of profound neurological disease. The objectives of this proposal are to further develop and apply new polymerase chain reaction-based amplification methods for single cells and in situ hybridization to (1) define the types of cells in the CNS that harbor HIV genomes; and (2) determine the kind and relative abundancy of viral and cellular transcripts in infected and uninfected cells to gain insight into virus-host cell relationships and mechanisms of tissue damage. PCR in situ, in situ hybridization and double-label methods will be used to identify and enumerate all the types of cells in the CNS harboring HIV and determine whether infection is latent or productive. Similar methods will be used to map cellular and viral proteins that may be the mediators of CNS injury, such as the viral env gene products and the cytokines tissue necrosis factor and gamma interferon, to see if there is a quantitative and spatial correlation with the extent of neuropathology. This information should provide insight into how HIV damages the CNS as the foundations for improved treatment to prevent or ameliorate the effects of HIV on the CNS.

Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1996
Total Cost
Indirect Cost
Price, R W; Yiannoutsos, C T; Clifford, D B et al. (1999) Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team. AIDS 13:1677-85
Rehm, K; Lakshminaryan, K; Frutiger, S et al. (1998) A symbolic environment for visualizing activated foci in functional neuroimaging datasets. Med Image Anal 2:215-26
Liow, J S; Strother, S C; Rehm, K et al. (1997) Improved resolution for PET volume imaging through three-dimensional iterative reconstruction. J Nucl Med 38:1623-31
Sidtis, J J; Dafni, U; Slasor, P et al. (1997) Stable neurological function in subjects treated with 2'3'-dideoxyinosine. J Neurovirol 3:233-40
Price, R W (1996) AIDS dementia complex: a complex, slow virus ""model"" of acquired genetic neurodegenerative disease. Cold Spring Harb Symp Quant Biol 61:759-70
Rottenberg, D A; Sidtis, J J; Strother, S C et al. (1996) Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med 37:1133-41
Wang, G J; Thayer, S A (1996) Sequestration of glutamate-induced Ca2+ loads by mitochondria in cultured rat hippocampal neurons. J Neurophysiol 76:1611-21
Price, R W (1996) The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex: introduction. J NeuroAIDS 1:1-29
Price, R W (1996) Neurological complications of HIV infection. Lancet 348:445-52
Price, R W (1995) Management of AIDS dementia complex and HIV-1 infection of the nervous system. AIDS 9 Suppl A:S221-36

Showing the most recent 10 out of 45 publications